Today: 21 May 2026
Arista Networks stock slips again as traders eye CPI and Feb. 16 earnings
10 January 2026
1 min read

Arista Networks stock slips again as traders eye CPI and Feb. 16 earnings

New York, January 9, 2026, 21:14 EST — Market closed.

  • Arista Networks shares slipped 0.7% Friday, underperforming the wider tech sector’s gains.
  • The stock fell sharply on Thursday, moving further away from its recent high.
  • Coming next: U.S. CPI on Jan. 13, followed by Arista’s earnings on Feb. 16.

Arista Networks, Inc. shares slipped 0.7% to close at $122.89 on Friday, while the Invesco QQQ Trust ETF gained 1.0%. The drop puts Arista firmly in focus as Monday’s trading approaches.

Arista’s stock slipped 4.89% Thursday, sitting roughly 25% below its 52-week peak, according to MarketWatch data. The company, which brands itself as a “client-to-cloud” networking provider for AI, data centers, and campuses, has become a key indicator for data-center networking spending linked to AI buildouts—a sector known for swift shifts in hardware stocks. MarketWatch

Rate bets are factoring in the latest data. U.S. payrolls increased by 50,000 in December, missing the 60,000 forecast, while the unemployment rate ticked down to 4.4%, according to a Reuters report; “it gives the Fed the ability to cut rates,” said Adam Sarhan, CEO of 50 Park Investments. Reuters

Analysts are pushing the spotlight back onto demand. “The market is not accurately reflecting” AI infrastructure demand in 2026 and 2027 estimates for Arista, UBS analyst David Vogt said in a note cited by MarketWatch. MarketWatch

Peers ended Friday on a mixed note. Cisco Systems dipped 0.1%, Ciena surged 2.5%, while Nvidia remained mostly flat.

Traders are eyeing the week’s lows on the chart. Arista’s shares ranged from $121.90 to $124.83 on Friday, after hitting $122.81 the previous day, according to StockAnalysis.com data.

Arista’s next major event is its earnings release, set for Feb. 16 after market close. Analysts expect an EPS of $0.76, according to TipRanks.

But the risk is clear: the stock already factors in a lot of positive news. If hyperscalers — major cloud providers running massive data centers — start delaying orders or if competition intensifies, guidance could take a hit and volatility could stay elevated.

Before Arista’s earnings, markets face a key macro update Tuesday. The Labor Department is set to release December’s U.S. consumer price index at 8:30 a.m. ET on Jan. 13.

Stock Market Today

  • Sharda Cropchem Earnings Reveal Weak Cash Flow Despite Profit Growth
    May 20, 2026, 9:35 PM EDT. Sharda Cropchem Limited's (NSE:SHARDACROP) recent earnings report shows a statutory profit of ₹6.81 billion for the year ending March 2026, but free cash flow was significantly lower at ₹1.6 billion, resulting in a high accrual ratio of 0.23. This suggests the company's cash conversion is less than ideal, raising concerns about the sustainability of its earnings. Despite this, Sharda Cropchem's earnings per share (EPS) has grown impressively over the past three years. Investors remain cautious due to three warning signs surrounding the stock, with one marked as significant. The gap between profit and cash flow indicates that reported profits may overstate the company's underlying earning power.

Latest articles

SPAC ETF Up as SpaceX Heads for SPCX Ticker

SPAC ETF Up as SpaceX Heads for SPCX Ticker

21 May 2026
The SPAC and New Issue ETF, now trading as SPCK, closed up 0.64% at $22.09 on Wednesday after SpaceX filed for a $75 billion IPO under the fund’s old ticker. The fund reported $7.14 million in net assets and 41 holdings as of May 19. New listings included a $75 million IPO from Research Alliance III and filings from FutureCorp Space Acquisition 1 and JAB Acquisition I. The SEC proposed easing share issuance rules for public companies.
EnerSys Stock Flips After Earnings as Guidance Tops Trader Hopes

EnerSys Stock Flips After Earnings as Guidance Tops Trader Hopes

21 May 2026
EnerSys shares rose in after-hours trading after the company posted fourth-quarter adjusted earnings of $3.19 per share on $988 million in revenue, both above analyst estimates. The stock closed regular hours down 1.3% at $214.56, then quoted up 5.8% to $227. First-quarter profit guidance also topped forecasts. Management cited strong data center and defense demand, but noted continued weakness in motive-power and transportation.
Silexion Soars After Cancer Study, Liquidity and Nasdaq Issues Linger for SLXN

Silexion Soars After Cancer Study, Liquidity and Nasdaq Issues Linger for SLXN

21 May 2026
Silexion Therapeutics shares surged 97% to $0.5298 on Wednesday with over 325 million shares traded, then fell 9.5% after hours. The move followed news that Israel approved a Phase 2/3 trial of its lead pancreatic cancer drug, SIL204. Silexion reported a Q1 net loss of $2.7 million and $2.4 million in cash. The company plans a 1-for-10 reverse share split by early June.
Bank of America stock dips after-hours after $3 billion debt call, with earnings next week
Previous Story

Bank of America stock dips after-hours after $3 billion debt call, with earnings next week

Lloyds share price clings to £1 as investors eye inflation data and Jan 29 results
Next Story

Lloyds share price clings to £1 as investors eye inflation data and Jan 29 results

Go toTop